![Pyoderma gangrenosum–like facial ulcers in a woman associated with cocaine use and cANCA/anti-PR3+, pANCA/anti-MPO– serology - JAAD Case Reports Pyoderma gangrenosum–like facial ulcers in a woman associated with cocaine use and cANCA/anti-PR3+, pANCA/anti-MPO– serology - JAAD Case Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/480c0043-4efc-47a3-a793-a108f4a50975/gr1.jpg)
Pyoderma gangrenosum–like facial ulcers in a woman associated with cocaine use and cANCA/anti-PR3+, pANCA/anti-MPO– serology - JAAD Case Reports
![References in Cocaine abuse: Dermatologic manifestations and therapeutic approaches - Journal of the American Academy of Dermatology References in Cocaine abuse: Dermatologic manifestations and therapeutic approaches - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/748497e0-954f-4554-a5f6-d5ba9d19755a/gr4_lrg.jpg)
References in Cocaine abuse: Dermatologic manifestations and therapeutic approaches - Journal of the American Academy of Dermatology
![References in Nasal septal and mucosal disease associated with pyoderma gangrenosum in a cocaine user - JAAD Case Reports References in Nasal septal and mucosal disease associated with pyoderma gangrenosum in a cocaine user - JAAD Case Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/eb50e284-c1a5-4f7b-8fb0-41a2c1a84d11/gr4_lrg.jpg)
References in Nasal septal and mucosal disease associated with pyoderma gangrenosum in a cocaine user - JAAD Case Reports
![Levamisole-induced leukocytoclastic vasculitis and neutropenia in a patient with cocaine use: An extensive case with necrosis of skin, soft tissue, and cartilage | Addiction Science & Clinical Practice | Full Text Levamisole-induced leukocytoclastic vasculitis and neutropenia in a patient with cocaine use: An extensive case with necrosis of skin, soft tissue, and cartilage | Addiction Science & Clinical Practice | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1940-0640-7-19/MediaObjects/13722_2011_Article_114_Fig5_HTML.jpg)